The Scientist

» cancer drugs

Most Recent

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.

0 Comments

image: Lavish Spending at MD Anderson

Lavish Spending at MD Anderson

By | May 28, 2013

The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.

0 Comments

image: Spinning Clinical Trials

Spinning Clinical Trials

By | January 16, 2013

Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.

0 Comments

image: $18M Grant to Be Re-reviewed

$18M Grant to Be Re-reviewed

By | June 1, 2012

A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.

5 Comments

image: Collecting Cancer Data

Collecting Cancer Data

By | March 29, 2012

Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS